|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquired_by
|
gptkb:Daiichi_Sankyo
|
|
gptkbp:acquisition_year
|
gptkb:2008
|
|
gptkbp:awards
|
Various industry awards
|
|
gptkbp:challenges
|
Legal issues
Market competition
Quality control issues
Regulatory scrutiny
Patent disputes
|
|
gptkbp:community_engagement
|
gptkb:Yes
|
|
gptkbp:employees
|
over 10,000
|
|
gptkbp:environmental_initiatives
|
gptkb:Yes
|
|
gptkbp:founded
|
gptkb:1961
|
|
gptkbp:founder
|
gptkb:B._D._Sanghvi
|
|
gptkbp:global_presence
|
Over 125 countries
|
|
gptkbp:headquarters
|
gptkb:Haryana,_India
gptkb:Gurgaon,_India
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ranbaxy Laboratories Limited
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:key_people
|
gptkb:Shivinder_Mohan_Singh
gptkb:Malvinder_Mohan_Singh
Atul Sobti
|
|
gptkbp:market_cap
|
$3.2 billion (2013)
|
|
gptkbp:notable_products
|
gptkb:Ciprofloxacin
gptkb:Omeprazole
gptkb:Ranitidine
Atorvastatin
Simvastatin
|
|
gptkbp:parent_company
|
gptkb:Daiichi_Sankyo_Company,_Limited
|
|
gptkbp:partnerships
|
Various global pharmaceutical companies
|
|
gptkbp:production_location
|
gptkb:India
gptkb:Romania
gptkb:South_Africa
gptkb:USA
|
|
gptkbp:products
|
Generic drugs
Over-the-counter medications
|
|
gptkbp:regulatory_compliance
|
gptkb:FDA
gptkb:WHO
gptkb:EMA
|
|
gptkbp:research_and_development
|
gptkb:Yes
|
|
gptkbp:revenue
|
$1.5 billion (2013)
|
|
gptkbp:social_responsibility
|
gptkb:Yes
|
|
gptkbp:stock_exchange
|
gptkb:BSE
NSE
|
|
gptkbp:subsidiary
|
gptkb:Ranbaxy_USA_Inc.
|
|
gptkbp:type
|
gptkb:Public
|
|
gptkbp:website
|
www.ranbaxy.com
|
|
gptkbp:bfsParent
|
gptkb:Ranbaxy_Pharmaceuticals_Inc.
gptkb:Ranbaxy_Laboratories_(Malaysia)_Sdn_Bhd
gptkb:Ranbaxy_(South_Africa)_(Pty)_Ltd.
|
|
gptkbp:bfsLayer
|
7
|